These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 6159505)

  • 21. [Experience with the use of interferon and its inducers in the treatment of trachoma].
    Babushkin VS
    Vestn Oftalmol; 1976; (2):48-50. PubMed ID: 1014186
    [No Abstract]   [Full Text] [Related]  

  • 22. Interferon therapy in chronic hepatitis B.
    Lancet; 1976 Nov; 2(7995):1122-3. PubMed ID: 62954
    [No Abstract]   [Full Text] [Related]  

  • 23. Interferon and ocular virus disease.
    Raju VK
    Indian J Ophthalmol; 1984; 32(5):429-31. PubMed ID: 6085834
    [No Abstract]   [Full Text] [Related]  

  • 24. [Action mechanism of interferon and interferon inducers in vivo].
    Suzuki F; Ishida N
    Nihon Rinsho; 1977 Sep; 35(9):2826-31. PubMed ID: 926379
    [No Abstract]   [Full Text] [Related]  

  • 25. [The antibacterial efficacy of preparations of interferon and its inducers].
    Spivak NIa; Grabchenko NI; Lazarenko LN; Tovt-Korshinskaia MI; Ganova LA; Timoshok NA; Krivokhatskaia LD; Mikhaĭlenko ON; Karpov AV; Mikhaĭlenko TI; Zotsenko VN
    Mikrobiol Z; 1999; 61(1):32-45. PubMed ID: 10330873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antigenic properties of interferons.
    Ogburn CA; Dalton BJ
    Tex Rep Biol Med; 1981-1982; 41():23-30. PubMed ID: 6184808
    [No Abstract]   [Full Text] [Related]  

  • 27. Interferon as therapeutic agent.
    Borecký L; Fuchsberger N
    Acta Virol; 1983 Jul; 27(4):359-70. PubMed ID: 6195902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interferon and interferon inducers in the treatment of Herpesvirus and Adenovirus eye diseases.
    Maichuk YF
    Rev Int Trach Pathol Ocul Trop Subtrop; 1980; 57(2-3):61-9. PubMed ID: 6165061
    [No Abstract]   [Full Text] [Related]  

  • 29. Interferon: anticancer agent having multifarious activity.
    Yabrov AA
    Prog Clin Cancer; 1982; 8():99-145. PubMed ID: 6185970
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of cyclophosphamide on intestinal absorption of radiophosphate in man].
    Gennari C; Vattimo A; Nardi P
    Boll Soc Ital Biol Sper; 1975 Feb; 51(3):90-2. PubMed ID: 1056787
    [No Abstract]   [Full Text] [Related]  

  • 31. [Cytostatic treatment with the streptomyces extract mitomycin].
    Böhnel J; Stacher A
    Wien Med Wochenschr; 1968 Jan; 118(2):29-32. PubMed ID: 5243841
    [No Abstract]   [Full Text] [Related]  

  • 32. Letter: Interferon in acute leukaemia in children.
    Ahström L; Dohlwitz A; Strander H; Carlström G; Cantell K
    Lancet; 1974 Feb; 1(7849):166-7. PubMed ID: 4129735
    [No Abstract]   [Full Text] [Related]  

  • 33. [Special preparation of intravenously injectable gamma globulin].
    Blatrix C; Bosquet P; Audran R; Steinbuch M
    Presse Med (1893); 1969 Jan; 77(5):159-61. PubMed ID: 4181631
    [No Abstract]   [Full Text] [Related]  

  • 34. [The search for low-molecular interferon inducers--an important trend in the development of chemotherapy].
    Pershin GN
    Farmakol Toksikol; 1985; 48(3):16-8. PubMed ID: 2411591
    [No Abstract]   [Full Text] [Related]  

  • 35. [Prospects in the use of the interferon system in the prevention and treatment of viral infections].
    Dianzani F; Viano I; Zucca M
    G Ital Chemioter; 1974; 21(2):67-78. PubMed ID: 4471329
    [No Abstract]   [Full Text] [Related]  

  • 36. Proposed guidelines for protocol studies. Prepared by a Committee of the Chronic Leukemia-Myeloma Task Force, National Cancer Institute.
    Cancer Chemother Rep 3; 1968 Dec; 1(1):13-6. PubMed ID: 4917774
    [No Abstract]   [Full Text] [Related]  

  • 37. [Perspectives on interferon research and on its therapeutic use].
    Montagnier L
    Arch Inst Pasteur Tunis; 1981; 58(3):297-312. PubMed ID: 6172080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferon: its inducers and some aspects of host resistance in malignancy.
    Merigan TC
    Cancer Chemother Rep; 1974; 58(4):571-8. PubMed ID: 4604626
    [No Abstract]   [Full Text] [Related]  

  • 39. [The combined therapy of herpesvirus infection (experimental and clinical data)].
    L'vov ND; Samoĭlovich EO; Barinskiĭ IF
    Vopr Virusol; 1992; 37(1):8-16. PubMed ID: 1384242
    [No Abstract]   [Full Text] [Related]  

  • 40. [Interferons and inductors of their synthesis (review)].
    Malashenkova IK; Tazulakhova EB; Didkovskiĭ NA
    Ter Arkh; 1998; 70(11):35-9. PubMed ID: 9949456
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.